James B Jones

Insider

First SEC filing: Jan. 29, 2016 · Latest: Jan. 29, 2016

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 6 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

6 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
Nov. 20, 2017	PCRX	S	850	$41.11	$34,944	16,823 Direct	-4.81%	Disposed	-41.4% (price as of 2026-08-20)
June 14, 2017	PCRX	A	15,000	—	—	15,000 Direct	—	Acquired	(price as of 2026-08-20)
June 14, 2017	PCRX	A	7,500	—	—	17,313 Direct	+76.43%	Acquired	(price as of 2026-08-20)
June 5, 2017	PCRX	S	767	$43.32	$33,226	9,813 Direct	-7.25%	Disposed	-44.4% (price as of 2026-08-20)
Dec. 7, 2016	PCRX	A	10,000	—	—	10,000 Direct	—	Acquired	(price as of 2026-08-20)
June 15, 2016	PCRX	A	17,500	—	—	17,500 Direct	—	Acquired	(price as of 2026-08-20)
June 15, 2016	PCRX	A	8,750	—	—	10,250 Direct	+583.33%	Acquired	(price as of 2026-08-20)
Jan. 27, 2016	PCRX	P	500	$62.50	$31,250	1,500 Direct	+50.00%	Acquired	-61.5% (price as of 2026-08-20)
Jan. 12, 2016	PCRX	P	1,000	$66.00	$66,000	1,000 Direct	—	Acquired	-63.5% (price as of 2026-08-20)
Aug. 17, 2015	PCRX	A	40,000	—	—	40,000 Direct	—	Acquired	(price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
June 14, 2017	PCRX	Stock Option (Right to Buy)	Common Stock (15,000)	$44.20	June 14, 2027	15,000	Acquired
Dec. 7, 2016	PCRX	Stock Option (Right to Buy)	Common Stock (10,000)	$32.35	Dec. 7, 2026	10,000	Acquired
June 15, 2016	PCRX	Stock Option (Right to Buy)	Common Stock (17,500)	$40.34	June 15, 2026	17,500	Acquired
Aug. 17, 2015	PCRX	Employee Stock Option (Right to Buy)	Common Stock (40,000)	$61.90	Aug. 17, 2025	40,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Matched by name from proxy statements (DEF 14A) — verify against the filing.

President

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2015	$154,327	$120,000	—	$1,225,125	—	—	$420	$1,499,872

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.